Zobrazeno 1 - 10
of 340
pro vyhledávání: '"drug-induced liver disease"'
Autor:
JIANG Linshuang, CHEN Maowei
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 30, Pp 3772-3775 (2024)
Background Drug-induced liver injury is one of the most common adverse drug reactions, and atorvastatin is one of the widely used statin lipid-lowering drugs in clinical practice, which is susceptible to hepatic injury. Currently, there is limited re
Externí odkaz:
https://doaj.org/article/00db0a2f37dc4bbfa95704b71439e429
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 2, Pp 167-177 (2024)
INTRODUCTION. The pathogenesis of antibiotic-associated drug-induced liver injury (DILI) in children has not been fully elucidated to date. Certain genotypes in patients increase the probability of developing DILI. Therefore, the identification of ph
Externí odkaz:
https://doaj.org/article/931e148f11904fb9ac2f7b9613665199
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
BackgroundThe gut microbiota and plasma metabolites play important roles in the progression of drug-induced liver injury (DILI). We investigated the causal associations between the gut microbiota, plasma metabolome, and DILI.MethodsThe summary data f
Externí odkaz:
https://doaj.org/article/0db322d72f464ee6916b026b2aec01bb
Publikováno v:
Scientia Pharmaceutica, Vol 92, Iss 1, p 15 (2024)
Lamotrigine, widely used for managing epilepsy and bipolar disorder, carries potential side effects, including severe anticonvulsant hypersensitivity syndrome (AHS) or drug rash with eosinophilia and systemic symptoms (DRESS), which may lead to hepat
Externí odkaz:
https://doaj.org/article/4356a2c199ae42d1ba7236b8120bf4fe
Autor:
Manon N. G. J. A. Braat, Sander C. Ebbers, Ahmed A. Alsultan, Atal O. Neek, Rutger C. G. Bruijnen, Maarten L. J. Smits, Joep de Bruijne, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Publikováno v:
Diagnostics, Vol 13, Iss 24, p 3652 (2023)
Purpose: Trans-arterial radioembolization is a well-studied tumoricidal treatment for liver malignancies; however, consensus and evidence regarding periprocedural prophylactic medication (PPM) are lacking. Methods: A single-center retrospective analy
Externí odkaz:
https://doaj.org/article/573168a4a9d14c029fc7c5b7fa1661bd
Autor:
Daniel Vásquez, Luisa Fernanda Ahunca, Diana Restrepo, Marle Duque, Lina María Ramírez, Luis Guillermo Toro
Publikováno v:
Medicina U.P.B., Vol 41, Iss 1, Pp 3-11 (2022)
Objetivo: este estudio busca describir los individuos evaluados por sobredosis de acetaminofén entre 2019 y 2020 en un centro de referencia de trasplante hepático en Colombia. Metodología: estudio derivado del análisis secundario de historias cl
Externí odkaz:
https://doaj.org/article/bc9e05dbdb1943b0aa95eaca777762d7
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 1, Pp 14-21 (2022)
Among drug-induced liver injuries (DILI), the cholestatic type is second in frequency (from 20 to 40%), the most common is the hepatocellular variant (up to 78%). For this reason, practitioners of various specialties, including neurologists and psych
Externí odkaz:
https://doaj.org/article/ef5b038f4ab54cf09ae2517ccb0bdea4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xian He, Ming-Xi Zhou, Cheng Cheng, Shan-Shan Li, Yuan Gao, Zhi-Tao Ma, Xin-Hua Song, Zhao-Fang Bai, Zheng-Sheng Zou, Xiao-He Xiao, Jia-Bo Wang, Ya-Wen Lu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background and aims: Chronic drug-induced liver injury (DILI) is a rare but under-researched adverse drug reaction–related disease, which is highly likely to progress into liver fibrosis and even cirrhosis. In this study, metabolomics was used to s
Externí odkaz:
https://doaj.org/article/b5b29f16a52546ab8b36b5da4b105609
Publikováno v:
Revista Colombiana de Psiquiatría. 52:165-170
Resumen Introduccion Los antipsicoticos son medicamentos que pueden producir elevaciones transitorias de las enzimas hepaticas. La clozapina es un antipsicotico atipico usado en el tratamiento de la esquizofrenia refractaria a los antipsicoticos conv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2129dcc4d02b2ad97fc759960c1c82ca
https://doi.org/10.1016/j.rcp.2021.04.010
https://doi.org/10.1016/j.rcp.2021.04.010